NOACs associated with lower risk for diabetic complications and mortality compared with warfarin

A retrospective cohort study of patients with atrial fibrillation and diabetes found that the use of non–vitamin K antagonist oral anticoagulants (NOAC) was associated with a lower risk of diabetes complications and mortality than warfarin. These findings suggest that NOAC may be a better therapeutic choice for this patient population. The study is published in Annals of Internal Medicine.

source https://medicalxpress.com/news/2022-02-noacs-diabetic-complications-mortality-warfarin.html